Lundbeck
The Global Regulatory Strategy Lead shapes and drives the global regulatory strategy for new CNS treatments, coordinating execution for Phase 2 development programs. This role involves representing Regulatory Affairs in cross-functional teams, leading the Regulatory Focus Team, and providing scientific insights to key project decisions. The position requires building partnerships, identifying regulatory risks, and contributing to clinical development plans across the lifecycle.
Headquarters
Copenhagen, Hovedstaden, Denmark
Company Size
5001-10000 employees
Founded
1915
Lundbeck is a global biopharmaceutical company headquartered in Copenhagen, Denmark, focused on the research, development and commercialization of treatments for disorders of the brain. Its therapeutic areas include neurology and psychiatry—such as depression, schizophrenia, Alzheimer’s and Parkinson’s diseases, epilepsy and migraine—and it provides patient resources, awareness campaigns and community engagement. Lundbeck invests in neuroscience research and partnerships to advance innovative medicines and improve outcomes for people living with brain disorders worldwide. The company works with healthcare providers, payers and patient organizations to address unmet needs in brain health.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Lundbeck.
Lundbeck didn’t post a salary, so this is our estimate from similar listings.
Regulatory Strategy Manager
Vertex
Director, Global Regulatory Strategy Lead - Regulatory Affairs
Olema Oncology
Director, Global Regulatory Strategy Lead - Regulatory Affairs
Olema Oncology
Regulatory Affairs Strategy Director
AstraZeneca
Director, Global Regulatory Affairs
Angitia Biopharmaceuticals
Director, Regulatory Affairs Strategy
Travere Therapeutics